These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20394904)

  • 1. Screening for left ventricular systolic dysfunction: is imaging a solution?
    Atherton JJ
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):421-8. PubMed ID: 20394904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
    Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
    J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.
    Murtagh G; Dawkins IR; O'Connell R; Badabhagni M; Patel A; Tallon E; O'Hanlon R; Ledwidge MT; McDonald KM
    Eur J Heart Fail; 2012 May; 14(5):480-6. PubMed ID: 22416086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical criteria and biochemical markers for the detection of systolic dysfunction.
    Yamamoto K; Burnett JC; Bermudez EA; Jougasaki M; Bailey KR; Redfield MM
    J Card Fail; 2000 Sep; 6(3):194-200. PubMed ID: 10997744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective strategies to screen for left ventricular systolic dysfunction in the community--a concept.
    Senior R; Galasko G
    Congest Heart Fail; 2005; 11(4):194-8, 211. PubMed ID: 16106121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
    Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tissue Doppler-derived ventricular asynchrony in patients with left bundle branch block but not advanced heart failure.
    Citro R; D'Andrea A; Patella MM; Ducceschi V; Provenza G; De Luca G; Calabrò R; Gregorio G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):568-74. PubMed ID: 17667026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?
    Galasko GI; Barnes SC; Collinson P; Lahiri A; Senior R
    Eur Heart J; 2006 Jan; 27(2):193-200. PubMed ID: 16267076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.
    Heidenreich PA; Gubens MA; Fonarow GC; Konstam MA; Stevenson LW; Shekelle PG
    J Am Coll Cardiol; 2004 Mar; 43(6):1019-26. PubMed ID: 15028361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women.
    Hedberg P; Lönnberg I; Jonason T; Nilsson G; Pehrsson K; Ringqvist I
    Am Heart J; 2004 Sep; 148(3):524-9. PubMed ID: 15389243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study].
    Gavazzi A; De Maria R; Grosu A; Iacovoni A; Fontana A; Gori M; Ferrari P; Canova P; Calabrese A; Filippi A; Rutili MR; Donzelli L; Parolini M; Senni M
    G Ital Cardiol (Rome); 2014 May; 15(5):313-22. PubMed ID: 25002172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.
    Paulus WJ; Tschöpe C; Sanderson JE; Rusconi C; Flachskampf FA; Rademakers FE; Marino P; Smiseth OA; De Keulenaer G; Leite-Moreira AF; Borbély A; Edes I; Handoko ML; Heymans S; Pezzali N; Pieske B; Dickstein K; Fraser AG; Brutsaert DL
    Eur Heart J; 2007 Oct; 28(20):2539-50. PubMed ID: 17428822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
    Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of echocardiography in the screening of patients at risk of heart failure.
    Colonna P; Pinto FJ; Sorino M; Bovenzi F; D'Agostino C; de Luca I
    Am J Cardiol; 2005 Dec; 96(12A):42L-51L. PubMed ID: 16399092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of N-terminal pro-B type natriuretic peptide in a pre-operative setting to predict left ventricular systolic dysfunction on echocardiogram.
    Messer PB; Singh R; McAuley FT; Handley G; Peaston B; Snowden CP
    Anaesthesia; 2008 May; 63(5):482-7. PubMed ID: 18412645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of pocket-sized echocardiography to assess left ventricular systolic function prior to permanent pacemaker implantation.
    Lau L; Ducas R; Rizkallah J; Jassal DS; Seifer CM
    Cardiovasc Ultrasound; 2015 Mar; 13():10. PubMed ID: 25888874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.